The Analytic Microscopy Core Facility (AMC) was established in 1999 to serve as a centralized shared resource that provides scientific and technical expertise in optical microscopy applications. The AMC is an invaluable resource for Cancer Center researchers interested in intracellular trafficking and sub-cellular localization of molecules involved in protein phosphorylation, signal transduction, cell cycle progression, cellto- cell contact, cell motility, cell differentiation, apoptosis, angiogenesis, invasion or metastasis, DNA repair, and gene expression and drug discovery. The AMC's primary goal is to provide Cancer Center investigators with access to the latest optical microscopy imaging systems, including: widefield fluorescence and confocal microscopy;image analysis and laser capture microdissection. In the last five years the AMC Facility has actively contributed significantly to the science of the Cancer Center. Work supported by the AMC Facility has resulted in nearly 100 publications since 2000. The AMC Core has added new state-of-art instrumentation resulting in a steady rise in usage of the Core Facility by the Cancer Center investigators. The future plans of the AMC Facility are to maximize the potential of the current instruments and further develop advanced microscopy applications. To achieve these goals the AMC Facility will implement a series of initiatives to educate and train intra- and extramurally-funded investigators in the use of advanced microscopy and imaging techniques. In addition the Core will focus on facilitating the investigators awareness and access to confocal and fluorescence microscopy. To this end the AMC Facility will offer a series of general microscopy workshops in these areas, to assist in growing the knowledge and skill base of the facility's users.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA076292-12
Application #
8055326
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2010-02-01
Budget End
2011-01-31
Support Year
12
Fiscal Year
2010
Total Cost
$107,266
Indirect Cost
Name
H. Lee Moffitt Cancer Center & Research Institute
Department
Type
DUNS #
139301956
City
Tampa
State
FL
Country
United States
Zip Code
33612
Kahen, Elliot John; Brohl, Andrew; Yu, Diana et al. (2018) Neurofibromin level directs RAS pathway signaling and mediates sensitivity to targeted agents in malignant peripheral nerve sheath tumors. Oncotarget 9:22571-22585
Hoffman, Melissa A; Fang, Bin; Haura, Eric B et al. (2018) Comparison of Quantitative Mass Spectrometry Platforms for Monitoring Kinase ATP Probe Uptake in Lung Cancer. J Proteome Res 17:63-75
Puri, Sonam; Hyland, Kelly A; Weiss, Kristine Crowe et al. (2018) Prediction of chemotherapy-induced nausea and vomiting from patient-reported and genetic risk factors. Support Care Cancer 26:2911-2918
Gonzalez, Brian D; Small, Brent J; Cases, Mallory G et al. (2018) Sleep disturbance in men receiving androgen deprivation therapy for prostate cancer: The role of hot flashes and nocturia. Cancer 124:499-506
Eroglu, Zeynep; Zaretsky, Jesse M; Hu-Lieskovan, Siwen et al. (2018) High response rate to PD-1 blockade in desmoplastic melanomas. Nature 553:347-350
Lu, Yingchang; Beeghly-Fadiel, Alicia; Wu, Lang et al. (2018) A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk. Cancer Res 78:5419-5430
Phadke, Manali; Remsing Rix, Lily L; Smalley, Inna et al. (2018) Dabrafenib inhibits the growth of BRAF-WT cancers through CDK16 and NEK9 inhibition. Mol Oncol 12:74-88
Kasting, Monica L; Christy, Shannon M; Sutton, Steven K et al. (2018) Florida physicians' reported use of AFIX-based strategies for human papillomavirus vaccination. Prev Med 116:143-149
Jiang, Kun; Neill, Kevin; Cowden, Daniel et al. (2018) Expression of CAS/CSE1L, the Cellular Apoptosis Susceptibility Protein, Correlates With Neoplastic Progression in Barrett's Esophagus. Appl Immunohistochem Mol Morphol 26:552-556
Park, Jae H; Rivière, Isabelle; Gonen, Mithat et al. (2018) Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia. N Engl J Med 378:449-459

Showing the most recent 10 out of 1254 publications